Page 1 of Clinical Trials for Drug bortezomib, 602 Total Matches
- 1TerminatedLast Updated: June 13, 2011Condition(s): Multiple Myeloma
- 2RecruitingLast Updated: December 5, 2011Condition(s): Disorder of Transplanted Kidney; Donor Specific Alloantibodies
- 3RecruitingLast Updated: January 18, 2012Condition(s): Kidney Transplant
- 4RecruitingLast Updated: December 23, 2011Condition(s): Lung or Prostatic Neoplasms; Colorectal or Kidney Neoplasms; Pancreatic Neoplasms; Leukemia, Myelogenous, Chronic Lymphocytic Leukemia, BCR-ABL Positive; Melanoma; CLL
- 5Not yet recruitingLast Updated: May 20, 2011Condition(s): Non-Hodgkin Lymphoma
- 6RecruitingLast Updated: January 9, 2012Condition(s): Amyloidosis
- 7RecruitingLast Updated: February 10, 2012Condition(s): Post-transplant Lymphoproliferative Disease; Solid Organ Transplant; Stem Cell Transplant (Bone Marrow Transplant); Epstein Barr Virus Infections
- 8RecruitingLast Updated: November 10, 2011Condition(s): Acute Myeloid Leukemia; Acute Myeloid Leukemia With Multilineage Dysplasia Following; Myelodysplastic Syndrome; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Recurrent Adult Acute Myeloid Leukemia; Secondary Acute Myeloid Leukemia
- 9RecruitingLast Updated: June 7, 2011Condition(s): Multiple Myeloma, Plasma Cell Leukemia
- 10TerminatedLast Updated: August 10, 2011Condition(s): Relapsed or Refractory Multiple Myeloma
- 11Active, not recruitingLast Updated: February 3, 2011Condition(s): Glioblastoma; Gliosarcoma
- 12Completed
- 13RecruitingLast Updated: February 3, 2012Condition(s): Multiple Myeloma
- 14Active, not recruitingLast Updated: October 25, 2010Condition(s): Lymphoma, Mantle-Cell; Leukemia, Lymphocytic, Chronic, B-Cell
- 15Active, not recruitingLast Updated: January 17, 2011Condition(s): Lymphoma, Mantle- Cell
- 16Active, not recruitingLast Updated: October 11, 2011Condition(s): Multiple Myeloma
- 17RecruitingLast Updated: January 11, 2012Condition(s): Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)
- 18CompletedLast Updated: November 28, 2011Condition(s): Multiple Myeloma
- 19Active, not recruitingLast Updated: June 14, 2010Condition(s): Multiple Myeloma; Relapsed Multiple Myeloma; Refractory Multiple Myeloma
- 20CompletedLast Updated: November 2, 2010Condition(s): Multiple Myeloma
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://www.clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+bortezomib
